Anna Eshoo: “I think that is really what has risen up in the testimony today. And that is what I think is really troubling.”

I think that the committee needs to take that into consideration.

The PBM Accountability Act will finally shed a light on the opaque drug pricing system.

Chairwoman Rosenworcel, for as long as I can remember, you have been in my view the leading voice about the need to close the digital divide and the homework gap.

The Medicaid Value-Based Payments for Patients Act will codify a CMS rule to help ensure Medicaid enrollees have access to breakthrough gene therapies.